Carcinoma of the penis staging: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(9 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{Carcinoma of the penis}}
{{Carcinoma of the penis}}


'''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; Joel Gelman, M.D. [mailto:jgelman@uci.edu], ''Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of    California,Irvine''
'''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; {{Swathi}}
 
==Overview==
==Overview==
Carcinoma of the penis may be classified into several subtypes based on [[TNM system]] and [[UICC]] staging system.


==Staging==
==Staging==
Line 10: Line 10:
|valign=top|
|valign=top|
|+
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|TNM}}
! style="background: #4479BA; width: 100px;" | {{fontcolor|#FFF|TNM}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF| Definition}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF| Definition}}
|-
|-
Line 20: Line 20:
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |Tis
| style="padding: 5px 5px; background: #DCDCDC;" |Tis
| style="padding: 5px 5px; background: #F5F5F5;" |Carcinoma in situ
| style="padding: 5px 5px; background: #F5F5F5;" |[[Carcinoma in situ]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |Ta
| style="padding: 5px 5px; background: #DCDCDC;" |Ta
| style="padding: 5px 5px; background: #F5F5F5;" |Non-invasice verrucous carcinoma
| style="padding: 5px 5px; background: #F5F5F5;" |Non-invasice [[verrucous carcinoma]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |T1a
| style="padding: 5px 5px; background: #DCDCDC;" |T1a
| style="padding: 5px 5px; background: #F5F5F5;" |Tumour invades subepithelial connective tissue, but has not spread to the lymph vessels or blood vessels
| style="padding: 5px 5px; background: #F5F5F5;" |[[Tumor]] invades subepithelial [[connective tissue]], but has no lymphovascular invasion
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |T1b
| style="padding: 5px 5px; background: #DCDCDC;" |T1b
| style="padding: 5px 5px; background: #F5F5F5;" |Tumour invades subepithelial connective tissue and has spread to the lymphatic channels or blood vessels
| style="padding: 5px 5px; background: #F5F5F5;" |Tumor invades subepithelial connective tissue and has spread to the [[lymphatic]] channels or [[blood vessels]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |T2
| style="padding: 5px 5px; background: #DCDCDC;" |T2
| style="padding: 5px 5px; background: #F5F5F5;" |Tumour invades the erectile tissue ([[corpus spongiosum]] or cavernosum)
| style="padding: 5px 5px; background: #F5F5F5;" |Tumor invades the [[erectile tissue]] ([[corpus spongiosum]] or cavernosum)
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |T3
| style="padding: 5px 5px; background: #DCDCDC;" |T3
| style="padding: 5px 5px; background: #F5F5F5;" |Tumour invades the [[urethra]]
| style="padding: 5px 5px; background: #F5F5F5;" |Tumor invades the [[urethra]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |T4
| style="padding: 5px 5px; background: #DCDCDC;" |T4
Line 43: Line 43:
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |NX
| style="padding: 5px 5px; background: #DCDCDC;" |NX
| style="padding: 5px 5px; background: #F5F5F5;" |Regional lymph nodes cannot be assessed
| style="padding: 5px 5px; background: #F5F5F5;" |Regional [[lymph nodes]] cannot be assessed
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |N0
| style="padding: 5px 5px; background: #DCDCDC;" |N0
Line 60: Line 60:
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |M0
| style="padding: 5px 5px; background: #DCDCDC;" |M0
| style="padding: 5px 5px; background: #F5F5F5;" |No distant metastasis.
| style="padding: 5px 5px; background: #F5F5F5;" |No distant [[metastasis]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |M1
| style="padding: 5px 5px; background: #DCDCDC;" |M1
| style="padding: 5px 5px; background: #F5F5F5;" |Distant metastasis.
| style="padding: 5px 5px; background: #F5F5F5;" |Distant metastasis
|}
|}


Line 70: Line 70:
|valign=top|
|valign=top|
|+
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Stage}}
! style="background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Stage}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| T}}
! style="background: #4479BA; width: 100px;" | {{fontcolor|#FFF| T}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| N}}
! style="background: #4479BA; width: 100px;" | {{fontcolor|#FFF| N}}
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF| M}}
! style="background: #4479BA; width: 100px;" | {{fontcolor|#FFF| M}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" rowspan=2 |stage 0
| style="padding: 5px 5px; background: #DCDCDC;" rowspan=2 |Stage 0
| style="padding: 5px 5px; background: #F5F5F5;" |Tis
| style="padding: 5px 5px; background: #F5F5F5;" |Tis
| style="padding: 5px 5px; background: #F5F5F5;" |N0
| style="padding: 5px 5px; background: #F5F5F5;" |N0
Line 84: Line 84:
| style="padding: 5px 5px; background: #F5F5F5;" |M0
| style="padding: 5px 5px; background: #F5F5F5;" |M0
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |stage I
| style="padding: 5px 5px; background: #DCDCDC;" |Stage I
| style="padding: 5px 5px; background: #F5F5F5;" |T1a
| style="padding: 5px 5px; background: #F5F5F5;" |T1a
| style="padding: 5px 5px; background: #F5F5F5;" |N0
| style="padding: 5px 5px; background: #F5F5F5;" |N0
| style="padding: 5px 5px; background: #F5F5F5;" |M0
| style="padding: 5px 5px; background: #F5F5F5;" |M0
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" rowspan=3 |stage II
| style="padding: 5px 5px; background: #DCDCDC;" rowspan=3 |Stage II
| style="padding: 5px 5px; background: #F5F5F5;" |T1b
| style="padding: 5px 5px; background: #F5F5F5;" |T1b
| style="padding: 5px 5px; background: #F5F5F5;" |N0
| style="padding: 5px 5px; background: #F5F5F5;" |N0
Line 102: Line 102:
| style="padding: 5px 5px; background: #F5F5F5;" |M0
| style="padding: 5px 5px; background: #F5F5F5;" |M0
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |stage IIIA
| style="padding: 5px 5px; background: #DCDCDC;" |Stage IIIA
| style="padding: 5px 5px; background: #F5F5F5;" |T1-T3
| style="padding: 5px 5px; background: #F5F5F5;" |T1-T3
| style="padding: 5px 5px; background: #F5F5F5;" |N1
| style="padding: 5px 5px; background: #F5F5F5;" |N1
| style="padding: 5px 5px; background: #F5F5F5;" |M0
| style="padding: 5px 5px; background: #F5F5F5;" |M0
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |stage IIIB
| style="padding: 5px 5px; background: #DCDCDC;" |Stage IIIB
| style="padding: 5px 5px; background: #F5F5F5;" |T1-T3
| style="padding: 5px 5px; background: #F5F5F5;" |T1-T3
| style="padding: 5px 5px; background: #F5F5F5;" |N2
| style="padding: 5px 5px; background: #F5F5F5;" |N2
| style="padding: 5px 5px; background: #F5F5F5;" |M0
| style="padding: 5px 5px; background: #F5F5F5;" |M0
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" rowspan=3 |stage IV
| style="padding: 5px 5px; background: #DCDCDC;" rowspan=3 |Stage IV
| style="padding: 5px 5px; background: #F5F5F5;" |T4
| style="padding: 5px 5px; background: #F5F5F5;" |T4
| style="padding: 5px 5px; background: #F5F5F5;" |Any N
| style="padding: 5px 5px; background: #F5F5F5;" |Any N

Latest revision as of 17:44, 2 April 2019

Carcinoma of the penis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoma of the Penis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoma of the penis staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoma of the penis staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoma of the penis staging

CDC on Carcinoma of the penis staging

Carcinoma of the penis staging in the news

Blogs on Carcinoma of the penis staging

Directions to Hospitals Treating Carcinoma of the penis

Risk calculators and risk factors for Carcinoma of the penis staging

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Swathi Venkatesan, M.B.B.S.[2]

Overview

Carcinoma of the penis may be classified into several subtypes based on TNM system and UICC staging system.

Staging

TNM staging[1]

TNM Definition
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ
Ta Non-invasice verrucous carcinoma
T1a Tumor invades subepithelial connective tissue, but has no lymphovascular invasion
T1b Tumor invades subepithelial connective tissue and has spread to the lymphatic channels or blood vessels
T2 Tumor invades the erectile tissue (corpus spongiosum or cavernosum)
T3 Tumor invades the urethra
T4 Tumor invades other adjacent organs
Regional Lymph Nodes
NX Regional lymph nodes cannot be assessed
N0 Inguinal lymph nodes are not enlarged
N1 One unilateral inguinal lymph node is enlarged
N2 At least 2 inguinal lymph nodes are enlarged
N3 There is a fixed inguinal nodal mass or enlarged pelvic lymph nodes on one or both sides of the body
Distant Metastasis
M0 No distant metastasis
M1 Distant metastasis

UICC staging[2]

Stage T N M
Stage 0 Tis N0 M0
Ta N0 M0
Stage I T1a N0 M0
Stage II T1b N0 M0
T2 N0 M0
T3 N0 M0
Stage IIIA T1-T3 N1 M0
Stage IIIB T1-T3 N2 M0
Stage IV T4 Any N M0
Any T N3 M0
Any T Any N M1

References

  1. ↑ Stages of penile cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/penile/staging/?region=ab
  2. ↑ Stages of penile cancer. Canadian Cancer Society 2015. http://www.cancer.ca/en/cancer-information/cancer-type/penile/staging/?region=ab


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Carcinoma_of_the_penis_staging&oldid=1560676"